Liliana Goumnerova Selected Research

Liliana Goumnerova Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 02/2002
9	Glioma (Gliomas) 01/2023 - 04/2003
7	Brain Neoplasms (Brain Tumor) 01/2022 - 02/2002
4	Hydrocephalus (Hydrocephaly) 06/2019 - 10/2004
3	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 05/2013
2	Hemorrhage 11/2018 - 02/2010
2	Medulloblastoma 04/2016 - 04/2011
2	Necrosis 06/2002 - 02/2002
1	Ependymoma 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Brain Stem Neoplasms (Brain Stem Tumor) 12/2018
1	Carcinogenesis 01/2018
1	Melanoma (Melanoma, Malignant) 01/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2011
1	Intraoperative Complications 02/2010
1	Pulmonary Edema 02/2010
1	Carcinoma (Carcinomatosis) 09/2009
1	Central Nervous System Neoplasms 09/2009
1	Pinealoma (Pineoblastoma) 08/2008
1	Disease Progression 10/2007
1	Transverse Myelitis (Necrotizing Myelitis) 08/2006
1	Primitive Neuroectodermal Tumors (PNET) 08/2006
1	Myelitis 08/2006
1	Failure to Thrive 06/2005
1	Hypersensitivity (Allergy) 10/2003
1	Exanthema (Rash) 04/2003
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 06/2002

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2011
2	Histones (Histone)IBA 01/2018 - 05/2014
2	Choline (Choline Chloride)IBA 03/2004 - 02/2002
2	Protons (Proton)IBA 03/2004 - 06/2002
2	LipidsIBA 06/2002 - 02/2002
1	ceritinibIBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2019
1	ProdrugsIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	dipinacoline glutamateIBA 12/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	tovorafenibIBA 01/2017
1	CateninsIBA 04/2016
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 05/2014
1	Hormones (Hormone)IBA 10/2013
1	Proto-Oncogene Proteins B-rafIBA 05/2013
1	Transcription Factors (Transcription Factor)IBA 05/2013
1	MicroRNAs (MicroRNA)IBA 04/2011
1	Messenger RNA (mRNA)IBA 04/2011
1	RecoverinIBA 09/2009
1	Growth Hormone (Somatotropin)IBA 06/2005
1	N-acetylaspartate (N-acetyl aspartate)IBA 03/2004
1	Biomarkers (Surrogate Marker)IBA 03/2004
1	Indicators and Reagents (Reagents)IBA 03/2004
1	Procarbazine (Matulane)FDA Link 10/2003
1	Thioguanine (Tioguanine)FDA Link 10/2003
1	Lomustine (CCNU)FDA Link 10/2003
1	Vincristine (Oncovin)FDA LinkGeneric 10/2003
1	Carboplatin (JM8)FDA LinkGeneric 10/2003
1	EtanidazoleIBA 04/2003
1	1,3,4,5,6-pentachlorocyclohexene-1-oxideIBA 06/2002
1	NitrogenIBA 06/2002
1	CreatineIBA 06/2002
1	Gadolinium DTPA (Magnevist)FDA Link 02/2002
1	GadoliniumIBA 02/2002

Therapy/Procedure

7	Therapeutics 01/2019 - 10/2003
6	Drug Therapy (Chemotherapy) 04/2016 - 10/2003
3	Radiotherapy 01/2019 - 04/2003
2	Absorbable Gelatin Sponge 06/2019 - 11/2018
1	Precision Medicine 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2019
1	Immunotherapy 01/2019
1	Ventriculostomy 03/2014
1	Ventriculoperitoneal Shunt 02/2010
1	Craniospinal Irradiation 08/2006
1	Induction Chemotherapy 08/2006
1	Nephrectomy 10/2004